- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.02. | IMAGION BIOSYSTEMS LIMITED: Appendix 4G and Corporate Governance Statement | - | ASX | ||
| 27.02. | IMAGION BIOSYSTEMS LIMITED: FY25 Appendix 4E and Annual Report | - | ASX | ||
| 03.02. | Imagion Biosystems files IND application with FDA for cancer imaging agent | 2 | Investing.com | ||
| 03.02. | Imagion Biosystems beantragt FDA-Zulassung für bildgebendes Krebsdiagnostikum | 2 | Investing.com Deutsch | ||
| 01.02. | IMAGION BIOSYSTEMS LIMITED: IBX's IND Application Lodged with FDA for HER2 Phase 2 Trial | - | ASX | ||
| IMAGION BIOSYSTEMS Aktie jetzt für 0€ handeln | |||||
| 28.01. | IMAGION BIOSYSTEMS LIMITED: Appendix 4C and Quarterly Activities Report - December 2025 | - | ASX | ||
| 08.01. | IMAGION BIOSYSTEMS LIMITED: Cleansing Notice | - | ASX | ||
| 08.01. | IMAGION BIOSYSTEMS LIMITED: Application for quotation of securities - IBX | - | ASX | ||
| 08.01. | IMAGION BIOSYSTEMS LIMITED: Mercer Convertible Securities Conversion and Amendment | 1 | ASX | ||
| 06.01. | IMAGION BIOSYSTEMS LIMITED: Change of Director's Interest Notice - Robert Proulx | 1 | ASX | ||
| 06.01. | IMAGION BIOSYSTEMS LIMITED: Cleansing Notice | 1 | ASX | ||
| 06.01. | IMAGION BIOSYSTEMS LIMITED: Application for quotation of securities - IBX | 1 | ASX | ||
| 18.12.25 | IMAGION BIOSYSTEMS LIMITED: Updated Securities Trading Policy | 1 | ASX | ||
| 14.12.25 | IMAGION BIOSYSTEMS LIMITED: Cleansing Notice | - | ASX | ||
| 14.12.25 | IMAGION BIOSYSTEMS LIMITED: Application for quotation of securities - IBX | - | ASX | ||
| 10.12.25 | IMAGION BIOSYSTEMS LIMITED: Notification of cessation of securities - IBX | - | ASX | ||
| 04.12.25 | IMAGION BIOSYSTEMS LIMITED: Cleansing Notice | - | ASX | ||
| 04.12.25 | IMAGION BIOSYSTEMS LIMITED: Application for quotation of securities - IBX | - | ASX | ||
| 01.12.25 | Imagion Biosystems on track for Phase 2 breast cancer clinical trial early next year | 1 | Stockhead | ||
| 01.12.25 | IMAGION BIOSYSTEMS LIMITED: Positive Final WSU Trial Results To Support IND Submission | - | ASX |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 41,790 | -0,41 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,980 | +1,19 % | Siemens Healthineers: Stabilität als strategischer Vorteil | ||
| FRESENIUS | 46,140 | -0,56 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius von 55 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst James Vane-Tempest hob am Sonntag im... ► Artikel lesen | |
| BILLIONTOONE | 72,16 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 82,09 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 17,610 | -1,07 % | INVO Fertility, Inc.: INVO Fertility's Wisconsin Clinic Joins Progyny Network | ||
| PROCEPT BIOROBOTICS | 25,360 | 0,00 % | Truist cuts Procept BioRobotics stock price target on lower forecasts | ||
| ALIGNMENT HEALTHCARE | 18,590 | -1,43 % | Sekundärplatzierung belastet Alignment Healthcare-Aktie | ||
| FRESENIUS MEDICAL CARE | 39,870 | +0,43 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 47,50 auf 46,50 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Das Wachstum der Behandlungszahlen... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,945 | -5,19 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 24,860 | +3,97 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| BETA BIONICS | 11,090 | -2,55 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,830 | -1,97 % | Breaking Down Privia Health Gr: 5 Analysts Share Their Views | ||
| AVEANNA HEALTHCARE | 7,255 | -2,09 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| MEDTRONIC | 80,70 | +0,69 % | Medtronic's MiniMed Group Prices IPO Of 28 Mln Shares At $20.00/shr | WASHINGTON (dpa-AFX) - MiniMed Group Inc., a subsidiary of Medtronic plc (MDT), announced the pricing of its initial public offering of 28 million shares of its common stock at a price to the... ► Artikel lesen |
IMAGION BIOSYSTEMS LIMITED gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAGION BIOSYSTEMS LIMITED finden Sie auf Wallstreet Online.